Runx3 is required for the specification of TrkC-expressing mechanoreceptive trigeminal ganglion  neurons by Senzaki Kouji et al.
Runx3 is required for the specification of
TrkC-expressing mechanoreceptive trigeminal
ganglion  neurons
著者 Senzaki Kouji, Ozaki Shigeru, Yoshikawa
Masaaki, Ito Yoshiaki, Shiga Takashi
journal or
publication title
Molecular and cellular neuroscience
volume 43
number 3
page range 296-307
year 2010-03
権利 (C) 2009 Elsevier Inc
URL http://hdl.handle.net/2241/104892
doi: 10.1016/j.mcn.2009.12.003
 
 
 
 
 
Runx3 is required for the specification of TrkC-expressing 
mechanoreceptive trigeminal ganglion neurons  
 
 
 
 
 
Kouji Senzaki 1, Shigeru Ozaki 1, Masaaki Yoshikawa 1, 
Yoshiaki Ito 2, Takashi Shiga 1* 
 
 
 
1 Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 
Tennodai, Tsukuba, Ibaraki 305-8577, Japan. 
 
2 Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673, 
Singapore. 
 
* Corresponding author (e-mail: tshiga@md.tsukuba.ac.jp) 
 
 
 
 
Word count 
Abstract < 150 words 
 
 
Keywords: Runx3; Transcription factor; Trigeminal ganglion; TrkB; TrkC; Merkel 
endings; Mechanoreceptive neurons; Cell fate specification; Axon projection 
 
 
Abstract 
Sensory neurons project axons to specific peripheral and central targets according 
to their sensory modality. Runx3 is crucially involved in proprioceptive dorsal root 
ganglion neuron development. Runx3 is also expressed in trigeminal ganglion (TG) 
neurons. The role of Runx3 in the TG, however, is largely unknown, because the 
TG does not contain proprioceptive neurons. In Runx3-deficient (Runx3–/–) mice, 
TrkB-expressing TG neurons were increased, whereas TrkC-expressing TG 
neurons were decreased during TG neuron development. In Runx3–/– neonatal 
mice, TrkC-expressing TG neurons did not project to the Merkel cells in the outer 
root sheath (ORS) of whisker vibrissae peripherally and the spinal trigeminal 
nucleus pars interpolaris (Sp5I) centrally. These findings suggest that Runx3 is 
required for the specification of TrkC-expressing TG neurons, conveying 
mechanoreceptive signals from the Merkel cells in the ORS of the whisker 
vibrissae to the Sp5I. 
Introduction 
The mammalian Runt-related (Runx) transcription factor family comprises three 
members: Runx1, 2, and 3. These Runxs play important roles in developmental 
processes of various cell types, including hematopoietic cells, osteoblasts, and gastric 
epithelial cells (for reviews, see Coffman, 2003; Ito, 2004; 2008). Runx1 and Runx3 are 
also expressed in neuronal subtypes in the central and peripheral nervous systems 
(Simeone et al., 1995; Theriault et al., 2004; Theriault et al., 2005). In the dorsal root 
ganglion (DRG), Runx1 and Runx3 are expressed in a subpopulation of neurons. Runx1 
controls the cell fate specification and the axonal projections of nociceptive neurons, 
which convey information about pain, whereas Runx3 controls those of proprioceptive 
neurons, which convey information regarding muscle length and tension (for reviews, 
see Inoue et al., 2008, Marmigère and Ernfors, 2007). Furthermore, Runx1 and Runx3 
may be involved in the development of proprioceptive and nociceptive DRG neurons, 
respectively (Yoshikawa et al., 2007; Nakamura et al., 2008). Runx1 and Runx3 are 
also expressed in a subpopulation of trigeminal ganglion (TG) neurons, but their roles 
are not known (Levanon et al., 2002; Theriault et al., 2004).  
General somatosensory information is conveyed to the central nervous system at 
spinal levels through the DRG and at cranial levels through the TG. Although these 
ganglia have a similar function, they have distinct developmental origins. The DRG 
contains neurons originating from neural crest cells, whereas the TG contains neurons 
originating from neural crest cells and placodal ectoderm cells (Baker and 
Bronner-Fraser, 2001; Chan and Tam, 1988). Moreover, the DRG has nociceptive, 
mechanoreceptive, and proprioceptive neurons, whereas the TG has nociceptive and 
mechanoreceptive neurons. The proprioceptive neurons of the trigeminal system are 
located in the mesencephalic trigeminal nucleus in the brainstem (Lazarov, 2002). 
Though this does not mean that the proprioceptive neurons do not exist in the TG, no 
studies have shown proprioceptive neurons in the TG. In the developing DRG, Runx3 is 
necessary for the acquisition of proprioceptive neuron identities (Inoue et al., 2002; 
Levanon et al., 2002; Nakamura et al., 2008). The role of Runx3 in the developing TG, 
which lacks proprioceptive neurons, however, is largely unknown. 
In the present study, to elucidate the role of Runx3 in the development of TG 
neurons, we analyzed cell fate and axonal projections of TG neurons of Runx3-deficient 
(Runx3–/–) mice at the embryonic and neonatal stages. 
 
 
 
Results 
Changes of the expression of marker molecules in TG neurons of neonatal Runx3–/– 
mice Because Runx3–/– mice die soon after birth (Inoue et al., 2002), we first analyzed 
the TG of Runx3+/+ and Runx3–/– mice at postnatal day (P) 0. We examined whether the 
loss of Runx3 affects the number of TG neurons using NeuN as a pan-neuronal marker. 
The number of NeuN-expressing (NeuN+) neurons in the TG was not different between 
Runx3+/+ and Runx3–/– mice (Figs. 1A’-A’’’), suggesting that Runx3-deficiency does 
not affect the total number of TG neurons. 
To clarify the role of Runx3 in the cell fate of TG neurons, we examined the number 
of neurons expressing the neurotrophin receptor family members TrkA, TrkB, and TrkC 
(Figs. 1B-D). Compared with Runx3+/+ mice, the number of TrkB+ neurons in Runx3–/– 
mice increased to 143% (Fig. 1C’’’, Runx3+/+, 14475±378; Runx3–/–, 20653±676; 
p<0.0001), while that of TrkC+ neurons decreased to 38% (Fig. 1D’’’, 10605±714; 
4075±528; p<0.001). The number of TrkA+ neurons was not different in Runx3–/– mice 
(Fig. 1B’’’).  
To gain further insight into the role of Runx3 in TG neuron subtype specification, 
we examined the number of neurons that express calcium binding proteins (PV, Calr 
and CB) and neuropeptides (SOM, CGRP and SubP). A similar number of PV+ neurons 
was observed in the TG of Runx3+/+ (2810±164) and Runx3–/– (2794±114) mice (Fig. 
1E’’’), which is in great contrast to the lack of PV+ neurons observed in Runx3–/– DRG 
(Nakamura et al., 2008). Compared with Runx3+/+ mice, SOM+ TG neurons were 
dramatically decreased to 16% in Runx3–/– mice (Fig. 1F’’’, 395±50; 63±24; p<0.001), 
suggesting that SOM expression is downregulated in the absence of Runx3. The 
numbers of Calr+, CB+, CGRP+, and SubP+ TG neurons were not different between 
Runx3+/+ and Runx3–/– mice (Fig. S1). These findings suggest that Runx3 negatively 
regulates the expression of TrkB and positively regulates the expression of TrkC and 
SOM in the TG at P0. 
 
Correlation between the expression of Runx3 and marker molecules at the 
neonatal stage 
TrkB+ neurons were increased and TrkC+ neurons decreased in Runx3–/– TG at P0 (Fig. 
1). We next examined the expression of TrkB, TrkC and Runx3 by triple 
immunostaining in order to clarify the correlation between the expression of TrkB and 
TrkC, and the involvement of Runx3 in the regulation of these expressions in the TG. 
Runx3 was expressed in a subpopulation of TrkB+/TrkC– neurons, TrkB–/TrkC+ neurons, 
and TrkB+/TrkC+ neurons in Runx3+/+ mice (Figs. 2A’, 2A’’). In Runx3–/– mice, the 
number of TrkB–/TrkC+ neurons was decreased (Fig. 2G, Runx3+/+, 6643±593; Runx3–/–, 
2249±345; p<0.001) and that of TrkB+/TrkC– neurons was increased (Fig. 2G, 
13952±524; 16293±671; p<0.05) compared with that in Runx3+/+ mice. The number of 
TrkB+/TrkC+ neurons, however, was not significantly different between these mice 
(3055±509; 3649±455; Figs. 2A’’, 2B’’, 2G). These findings suggest that Runx3 
promotes the cell type specification of TrkB–/TrkC+ neurons, and suppresses the cell 
type specification of TrkB+/TrkC– neurons in the TG. 
We also examined the relationship of the co-expression of SOM or PV with Runx3 
and TrkC to elucidate the role of Runx3 in the expression of SOM and PV. In Runx3+/+ 
mice, TrkC and Runx3 were expressed in approximately 82% and 76% of SOM+ 
neurons, respectively (Figs. 2C’’, 2H). In Runx3+/+mice, approximately 280 neurons 
co-expressed SOM and Runx3 (278±49). The reduced number of SOM+ neurons 
(281±42) in Runx3–/– TG was comparable to the number of Runx3+/SOM+ neurons (Figs. 
2C’’, 2D’’, 2H). Taken together, these findings suggest that most SOM+ TG neurons 
co-express TrkC and Runx3, and Runx3 may positively regulates the expression of 
SOM cell-autonomously. 
TrkC was expressed in approximately 69% of PV+ neurons, but Runx3 was 
expressed in only 9% of PV+ neurons (Figs. 2E’’, 2I). In addition, the number of 
PV+/TrkC+ neurons was not significantly different between Runx3+/+ (1705±252) and 
Runx3–/– (1572±174) mice. In the DRG, most PV+ neurons co-express TrkC and Runx3 
in Runx3+/+ mice, and PV is not expressed in Runx3–/– mice (Nakamura et al., 2008). 
These findings suggest that Runx3 is not involved in the expression of PV in the TG, 
although the majority of PV+ neurons co-express TrkC, like in the DRG.  
 
Runx3 controls TrkB and TrkC expression from the early stage of TG neuron 
development 
To determine the embryonic stage at which Runx3 begins to control the expression of 
TrkB and TrkC, we estimated the number of TrkB+ and TrkC+ neurons from E10.5 to 
E13.5 (Fig. 3). Similar numbers of TrkB+ (Runx3+/+, 1982±99; Runx3–/–, 1683±39) and 
TrkC+ (4443±88; 4226±12) neurons were observed in Runx3+/+ and Runx3–/– mice at 
E10.5 (Figs. 3A’-3D’). Compared with Runx3+/+ mice, in Runx3–/– mice, the number of 
TrkB+ neurons was increased to 164% (8386±534; 13775±979; p<0.01), 145% 
(4424±236; 6436±616; p<0.05), and 164% (5371±599; 8810±668; p<0.01) at E11.5, 
E12.5, and E13.5, respectively (Figs. 3A’’-3A’’’’, 3B’’-3B’’’’, 3E), whereas that of 
TrkC+ neurons was decreased to 56% (8582±88; 4808±237; p<0.01), 70% (5856±357; 
4095±485; p<0.05), and 39% (6479±368; 2548±195; p<0.001) at E11.5, E12.5, and 
E13.5, respectively (Figs. 3C’’-3C’’’’, 3D’’-3D’’’’, 3F). We also examined TrkA+ and 
NeuN+ neurons at E11.5 and E13.5. The number of TrkA+ neurons was not different 
between Runx3+/+ and Runx3–/– mice at either embryonic stage. The number of NeuN+ 
neurons was not different at E11.5, but was slightly decreased at E13.5 in Runx3–/– mice 
(Fig. S2). These results suggest that Runx3 may begin to control the expression of TrkB 
and TrkC in TG neurons at E11.5. 
We then investigated the co-expression of TrkB, TrkC, and Runx3 in the TG at 
E10.5 and E13.5 (Fig. 4). At E10.5, Runx3, together with TrkB and TrkC, appeared in 
the TG of Runx3+/+ mice. Most of the TrkB+ neurons (91%) expressed TrkC in both 
Runx3+/+ and Runx3–/– TG (Figs. 4A’’, 4C’’, 4E), and most of the TrkB+/TrkC+ neurons 
(88%) expressed Runx3 in Runx3+/+ TG (Figs. 4A’’, 4E). The numbers of TrkB–/TrkC+ 
(2809±407; 2701±37), TrkB+/TrkC– (173±26; 159±64), and TrkB+/TrkC+ (1719±96; 
1623±136) neurons were not different between Runx3+/+ and Runx3–/– mice at E10.5, 
suggesting that Runx3 is not involved in regulating the expression of TrkB and TrkC at 
E10.5, despite the fact that Runx3 was expressed in the majority of TrkB+/TrkC+ 
neurons (Fig. 4E).  
At E13.5, TrkC was expressed in few TrkB+ neurons (1.3%) in Runx3+/+ mice. In 
Runx3+/+ mice, virtually all TrkC+ neurons (92%) and only a few TrkB+ neurons (3.7%) 
expressed Runx3 (Figs. 4B’’, 4F). In sharp contrast to Runx3+/+ mice, TrkC was 
expressed in most TrkB+ neurons (91%) in Runx3–/– mice, and the number of 
TrkB+/TrkC+ neurons increased by 35-fold (97±3; 3436±71; p<0.001, Figs. 4B’’, 4D’’, 
4F). In addition, the number of TrkB–/TrkC+ neurons was decreased to 4.9% (7001±180; 
341±7; p<0.001), whereas that of TrkB+/TrkC– neurons was not significantly different 
between Runx3+/+ (5491±76) and Runx3–/– (5146±428) mice at E13.5 (Figs. 4B’’, 4D’’, 
4F).  
These findings suggest that Runx3 positively regulates the expression of TrkC and 
negatively regulates the expression of TrkB in a cell-autonomous manner, and that 
Runx3 has a role in specifying TrkB/TrkC co-expressing TG neurons as 
single-expressing TrkB or TrkC TG neurons.  
 
Axonal projection of TrkB+ and TrkC+ TG neurons in Runx3–/– mice 
We next analyzed the axonal projections of TG neurons at E13.5 and P0. At E13.5, in 
Runx3+/+ mice, TG afferents reached the peripheral and central targets (Figs. 5, 6). In 
the peripheral projection of TG neurons of E13.5 Runx3+/+ mice, TrkB+ and TrkC+ 
afferents innervated the facial areas, including the large and small whisker vibrissae 
(Figs. 5A, 5C, 5E). In Runx3–/– mice, TrkB+ afferents projected to these areas, but few 
TrkC+ afferents were observed (Figs. 5B, 5D, 5F), despite the fact that a substantial 
number of TG neurons expressed TrkC (Figs. 3D’’’’, 3F). In the central projection, in 
Runx3+/+ mice, TrkB+ and TrkC+ afferents projected to the medial and lateral portion of 
the spinal trigeminal tract (Sp5t), respectively, in the metencephalon and 
myelencephalon (Figs. 6A, 6B). In Runx3–/– mice, TrkC+ afferents were not observed in 
the metencephalon and myelencephalon (Figs. 6C, 6D), and TrkB+ afferents were 
observed in the lateral portion of the Sp5t as well as the medial portion where TrkC+ 
afferents projected in Runx3+/+ mice (arrows in Figs. 6D’’’, 6D’’’’). Considering that 
most of the TrkC+ TG neurons co-express TrkB in Runx3–/– mice at E13.5 (Figs. 4D’, 
4D’’, 4F), these findings suggest that TrkB+/TrkC+ neurons (yellow in Figs. 4D’, 4D’’, 
4F) failed to project to the peripheral and central targets and TrkB+/TrkC– neurons 
(green in Figs. 4D’, 4D’’, 4F, 6D) projected to an aberrant central target in the lateral 
portion of the Sp5t in Runx3–/– mice.  
In Runx3–/– TG, most of the TrkC+ neurons co-expressed TrkB at E13.5, while 
approximately 60% of TrkC+ neurons co-expressed TrkB at P0 (Figs. 2F’’, 4D’’). To 
clarify the identities of the TrkB+/TrkC+ and TrkB–/TrkC+ neurons, we investigated 
TrkB+ and TrkC+ afferents at P0 (Fig. 7). TrkC+ afferents projected to the Merkel cells 
in the outer root sheath (ORS) of the large and small whisker vibrissae in Runx3+/+ mice 
(Fig. 7A, arrows in Figs. 7B, 7G; Fünfschilling et al., 2004), but not in Runx3–/– mice 
(Figs. 7D, 7E, 7H), while TrkB+ and TrkC+ afferents projecting to the reticular ending 
of the large whisker vibrissae were observed in both Runx3+/+ and Runx3−/− mice (Figs. 
7C, 7F). Some TrkC+ fibers that co-express TrkA, a thermo-nociceptive marker, were 
observed in Runx3+/+ mice, and similar fibers were also observed in Runx3–/– mice 
(arrowheads in Figs. 7G, 7H). In the brainstem, TrkC+ afferents projected to the spinal 
trigeminal nucleus pars interpolaris (Sp5I) and caudalis (Sp5C) in Runx3+/+ mice, 
whereas TrkC+ afferents projected to Sp5C, but not to the Sp5I in Runx3–/– mice (Fig. 8). 
TrkB+ afferents mainly projected to the Sp5I in Runx3+/+ mice, and similar TrkB+ 
afferents were observed in the Sp5I of Runx3–/– mice (Fig. 8).  
Some TrkC+ afferents were lost in the peripheral and central targets and TrkC+ 
neurons were decreased in Runx3–/– mice. Therefore, we examined whether apoptosis of 
TG neurons contributed to these phenotypes. The number of active caspase3+ apoptotic 
cells was not changed in Runx3+/+ and Runx3–/– mice from E11.5 to P0 (Fig. S3). In 
addition, because apoptosis is eliminated in Bax–/– TG (White et al., 1998), we 
examined the TrkC expression in the TG neurons and the TrkC+ afferents in the central 
target of Runx3–/–/Bax–/– double-knockout and Runx3+/+/Bax–/– control mice at E13.5. 
TrkC expression in the TG and the central projection of TrkC+ TG neurons in 
Runx3–/–/Bax–/– and Runx3+/+/Bax–/– mice were similar to that in Runx3–/– and Runx3+/+ 
mice, respectively (Figs. 6E-J). These results strongly suggest that Runx3 inactivation 
did not induce caspase3-dependent apoptosis, and that the reduction of TrkC+ neurons 
and the loss of TrkC afferents were not due to apoptosis. 
Finally, we examined the overall TG projections by injecting DiI crystals into TG in 
Runx3+/+ and Runx3–/– mice at E13.5, E16.5, and P0. DiI-labeled afferents projected to 
Sp5t at E13.5, and Sp5I at E16.5 and P0 in both Runx3+/+ and Runx3–/– mice. These 
projections, however, seemed smaller in Runx3–/– mice than those in Runx3+/+ mice (Fig. 
S4). 
In summary, both TrkC+ afferents and TrkC+/TrkB+ afferents projecting to the 
whisker and the lateral portion of Sp5t were lost in Runx3–/– mice at E13.5. TrkC+ 
afferents projecting to Merkel cells in the ORS of whisker vibrissae and the Sp5I were 
also lost in Runx3–/– mice at P0. Therefore, Runx3 is suggested to control the 
specification of TrkC+ TG neurons that project to the Merkel cells and Sp5I. 
 
Discussion 
In the present study, to clarify the roles of Runx3 in the development of TG neurons, 
we analyzed TG neuron profiles and their axonal projections in Runx3–/– mice. Runx3 
suppressed TrkB expression and maintained TrkC expression in a subpopulation of 
TrkB+/TrkC+ neurons, and Runx3 controlled the axonal projection of TrkC+ neurons 
innervating the Merkel cells in the ORS of whisker vibrissae peripherally and the Sp5I 
centrally. These findings suggest that Runx3 is necessary for the development of TrkC+ 
TG neurons that may convey mechanoreceptive signals from the Merkel cells in the 
ORS of whisker vibrissae to Sp5I.  
 
Runx3 is required for the axonal projection of mechanoreceptive neurons 
Several lines of evidence suggest that Runx3 is necessary for the specification of TrkC+ 
proprioceptive neurons in the DRG (Inoue et al., 2002; Levanon et al., 2002; Chen et al., 
2006; Kramer et al., 2006; Inoue et al., 2007; Nakamura et al., 2008). Runx3 is also 
expressed in a subpopulation of TG neurons from the early stages of development, but 
the roles of Runx3 in TG development are unknown. The TG contains cutaneous 
neurons, but not proprioceptive neurons, which are located in the mesencephalic 
trigeminal nucleus (for review, see Lazarov, 2007). In contrast to the TG, Runx3 was 
not expressed in the mesencephalic trigeminal nucleus (unpublished observations).  
   The present study showed that TrkB+/TrkC+ axonal projection was lost in the 
peripheral and central targets and TrkB+/TrkC− axonal projection was changed in the 
central target in Runx3–/– mice at E13.5, suggesting that Runx3 may be required for 
there axonal projections at the early stage of development. Furthermore, TrkC+ axonal 
projections were lost in the Merkel cells in the ORS of whisker vibrissae in the 
periphery and the Sp5I in the brainstem at P0, suggesting that Runx3 may be involved 
in the formation of mechanoreceptive afferent projections. On the other hands, TrkB+ 
and TrkC+ afferents projecting to the reticular ending of the large whisker vibrissae 
were observed in both Runx3+/+ and Runx3−/− mice. Runx3 was expressed strongly in 
the maxillary lobe neurons and much more weakly in the ophthalmic and mandibular 
lobe neurons of the TG (Fig. S5), suggesting that Runx3 may regulate the TG neurons 
mainly in the maxillary lobe. Three lines of evidence support the conclusion that the 
loss of TrkC+ axonal projections in Runx3–/– mice is not due to the apoptosis of TG 
neurons. First, the number of NeuN+ total TG neurons was not changed between 
Runx3+/+ and Runx3–/– mice at P0. Second, no changes in the number of apoptotic cells 
were observed in TG between Runx3+/+ and Runx3–/– mice from E11.5 to P0. Finally, 
TrkC+ axonal projections were still lost in Runx3–/–/Bax–/– mice in which apoptosis was 
blocked. These results strongly suggest that Runx3 is required for the proper 
development of TrkC+ TG neurons that project axons from the Merkel cells in the 
vibrissae to SP5I. Although the loss of TrkC+ axonal projection may not be due to the 
apoptosis, we can not exclude the possibility that the defects of TrkC+ axonal 
projections in the Merkel endings reflect the simple loss of the TrkC immunoreactivity. 
We are unable to address this possibility by general axonal markers, because TrkA+ 
axons project to this same region. 
   The mechanisms underlying the regulation of these axonal projections by Runx3 
remain to be examined. Previous studies reported that some TG neurons innervating the 
Merkel cells in the ORS of the vibrissae express TrkC, and that the Merkel nerve 
endings are lost when NT3/TrkC signaling is disrupted (Airaksinen et al., 1996; Fundin 
et al., 1997; Cronk et al., 2002; Fünfschilling et al., 2004). These studies suggest that 
NT3/TrkC signaling is necessary for the survival of TG neurons innervating the Merkel 
cells in the ORS (Airaksinen et al., 1996; Fundin et al., 1997; Cronk et al., 2002; 
Fünfschilling et al., 2004). It is also possible that NT3/TrkC signaling is required for 
axonal projections to the Merkel cells, as well as cell survival. An analysis of TrkC/Bax 
double knockout mice may address this possibility. Taken together, Runx3 may be 
involved in the axonal projections to the Merkel cells by regulating the expression of 
TrkC or other receptors for axonal guidance cues to the targets. 
   Chen et al (2006) showed that Runx3 may have a crucial role in the axonal 
projection of proprioceptive DRG neurons to the spinal cord. They used 
loss-of-function and gain-of-function experiments in chick embryos to show that high 
levels of Runx3 activity direct DRG axons to the ventral horn of the spinal cord, 
whereas intermediate levels of Runx3 activity direct DRG axons to the intermediate 
zone, and no Runx3 activity directs them to the dorsal horn. The present study 
suggested that Runx3 may be involved in the axonal projection of TG afferents to the 
spinal trigeminal nuclei. It is possible that similar mechanisms underlie the 
Runx3-mediated regulation of axonal projection of TG neurons and DRG neurons to 
their central targets. 
   In Drosophila, subsets of photoreceptor neurons express Runt (Run) and project 
their axons to the medulla, which is located in the distal part of the optic lobe. 
Interestingly, ectopic expression of run in photoreceptors that project to the lamina, the 
proximal part of the optic lobe, induces changes of the axonal projection to the medulla 
(Kaminker et al., 2002). Taken together, Runx family transcription factors may regulate 
the axonal projection of sensory neurons to central targets in both vertebrates and 
invertebrates.   
   We reported recently that TrkC+ neurons in the DRG are divided into two 
subpopulations: Runx3-dependent early-appearing proprioceptive neurons that project 
to the muscle spindles peripherally and the ventral/intermediate spinal cord centrally, 
and Runx3-independent late-appearing cutaneous neurons that project to the skin and 
the dorsal spinal cord (Nakamura et al., 2008). The present study showed that Runx3 is 
involved in the TG in the development of TrkC+ mechanoreceptive neurons, and that 
TrkC+ cutaneous neurons that innervate the facial skin are Runx3-independent. 
 
Runx3 represses TrkB expression and maintains TrkC expression in both TG and 
DRG 
The present immunohistochemical analyses showed that the numbers of TrkB+ and 
TrkC+ TG neurons were not changed in Runx3–/– mice at E10.5, suggesting that Runx3 
is not required for the initial appearance of TrkB and TrkC. The present study also 
revealed that most TrkB+ neurons express both TrkC and Runx3 in the TG at E10.5. By 
E13.5, TrkB+/TrkC+ TG neurons were segregated to TrkB+/TrkC– and TrkB–/TrkC+ 
neurons, and Runx3 was expressed in the TrkB–/TrkC+ but not the TrkB+/TrkC– neurons. 
These results suggest that Runx3 may be involved in the segregation of TrkB+/TrkC+ 
TG neurons into TrkB+ or TrkC+ TG neurons by repressing TrkB expression and 
maintaining TrkC expression in a cell autonomous manner. These roles of Runx3 were 
supported by the analyses of Runx3–/– mice where TrkB+ neurons were increased, 
whereas TrkC+ neurons were decreased in the TG at E13.5. In E13.5 Runx3–/– TG, the 
number of increased TrkB+/TrkC+ neurons is much smaller than the number of 
decreased TrkB–/TrkC+ neurons, suggesting the possibility that some prospective 
TrkB–/TrkC+ neurons were converted to become TrkB+/TrkC+ neurons, whereas the 
remaining half lost TrkC expression without an activation of TrkB at this early 
development stage. Similar regulation of the expression of TrkB and TrkC by Runx3 
was reported in the DRG (Inoue et al., 2002; Levanon et al., 2002, Chen et al., 2006; 
Kramer et al., 2006; Inoue et al., 2007; Nakamura et al., 2008). During the development 
of the DRG, TrkB+/TrkC+ neurons are segregated into TrkB+ mechanoreceptive neurons 
and TrkC+ proprioceptive neurons (Kramer et al., 2006; Inoue et al., 2007), and Runx3 
is involved in the repression of TrkB expression and the maintenance of TrkC 
expression. Taken together, it was shown that Runx3 plays similar roles in regulating 
the expression of TrkB and TrkC in both TG and DRG. 
 
Regulation of the expression of neuropeptides and calcium binding proteins by 
Runx3 in TG and DRG  
We examined the expression of neuropeptides and calcium-binding proteins in the TG 
of Runx3+/+ and Runx3–/– mice. The present study showed that most SOM+ neurons in 
the TG co-expressed Runx3 in Runx3+/+ mice, and that SOM+ neurons were decreased 
in Runx3–/– mice. These results suggest that Runx3 positively regulates the expression of 
SOM cell-autonomously. Because the number of SOM+ TG neurons is small and SOM+ 
axon projection to the Merkel cells in the ORS of whisker vibrissae and the Sp5I was 
not observed (data not shown in the present study; Rice et al., 1997), the identity of 
SOM+ TG neurons was not clear. We recently reported that SOM+ neurons were also 
decreased in Runx3–/– DRG (Nakamura et al., 2008). These results suggest that Runx3 
may regulate SOM expression in the TG as well as DRG. We also reported that the 
number of CGRP+ neurons is decreased in DRG of Runx3–/– mice (Nakamura et al., 
2008). In contrast, in the TG, CGRP expression was unchanged between Runx3+/+ and 
Runx3–/– mice. CGRP+ neurons are nociceptive in both TG and DRG (Price and Flores, 
2007). These results suggest that regulation of CGRP expression by Runx3 in TG may 
be different from that in the DRG.  
The present study showed that the expression of PV, Calr, and CB were unchanged 
in TG between Runx3+/+ and Runx3–/– mice. We recently reportSed that PV expression 
was virtually absent from the onset and Calr+ neurons were decreased, while CB+ 
neurons increased in the DRG of Runx3–/– mice (Nakamura et al., 2008). PV+ neurons 
and a subpopulation of Calr+ neurons are thought to be proprioceptive neurons in DRG 
(Copray et al., 1994; Honda, 1995; Kucera et al., 2002; Mu et al., 1993; Nakamura et al., 
2008). On the other hand, several previous reports suggest that PV+, Calr+, and CB+ 
neurons in the TG are nociceptive or mechanoreceptive neurons with nerve fibers that 
form Ruffini endings innervating the periodontal ligament (Ichikawa et al., 1993; 1994; 
1995; 1996; 1997; 2004; 2005; Ichikawa and Sugimoto, 1997). We observed TrkC+ 
afferents in the periodontal ligament in both Runx3+/+ and Runx3–/– mice (data not 
shown), suggesting that Runx3 may not influence the TrkC+ neurons innervating the 
periodontal ligament. Taken together, our data suggest that Runx3 may not participate 
in the development of nociceptive or mechanoreceptive neurons expressing PV, Calr, 
and CB, and that Runx3 plays separate roles in the development of the TG and DRG. 
 
Experimental Methods 
Genotyping and animal maintenance 
The strategy used to inactivate Runx3 in the mouse germline was described previously 
(Inoue et al., 2002; Li et al., 2002). Bax-deficient mice (Knudson et al., 1995) were 
purchased from the Jackson Laboratory (Bar Harbor, ME). Mice were bred in a clean 
room in the Laboratory Animal Resource Center at the University of Tsukuba. Runx3–/– 
mice and Runx3+/+ mice were obtained by mating Runx3+/– mice. Runx3–/–/Bax–/– double 
knockout mice and Runx3+/+/Bax–/– control mice were obtained by mating 
Runx3+/–/Bax+/– double heterozygotes. Timed embryos were obtained by overnight 
mating, and the morning when the vaginal plug was observed was considered E0.5. To 
genotype Runx3-deficiency, PCR was performed using primer pairs wild-type (NA, 
5’-GACTGTGCATGCACCTTTCACCAA-3’ and CB, 
5’-TAGGGCTCAGTAGCACTTACGTCG-3’) or mutant (NA and C2, 
5’-ATGAAACGCCGAGTTAACGCCATCA-3’) allele detection. For genotying of 
Bax-deficiency, PCR was performed using a set of three primers: Bax exon 5 forward 
primer (5’-TGATCAGAACCATCATG-3’), Bax intron 5 reverse primer 
(5’-GTTGACCAGAGTGGCGTAGG-3’), and Neo reverse primer 
(5’-CCGCTTCCATTGCTCAGCGG-3’). All experiments followed the Guide for the 
Care and Use of Laboratory Animals described by the National Institutes of Health 
(USA), and were approved by the Animal Experimentation Committee of the University 
of Tsukuba. 
 
Immunohistochemistry 
Immunohistochemistry was performed as previously described (Nakamura et al., 2008). 
For cryostat sections, E10.5 to E13.5 whole mouse embryos were immersed overnight 
at 4°C in a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 
7.4). Newborn mice were perfused transcardially with the same fixative and immersed 
overnight at 4˚C. The heads were dissected and immersed in 20% sucrose solution in 
0.1M phosphate buffer and frozen in Tissue Tek O.C.T. compound (Sakura Finetek, 
Japan). Horizontal, sagittal, or coronal sections (10 or 12 µm) of heads were cut using a 
cryostat (HM 500 OM; Microm, Germany) and collected onto MAS-coated glass slides 
(Matsunami Glass, Japan) and air-dried for 1 hour. If needed, sections were subjected to 
heat-induced epitope retrieval by heating to 105˚C for 5 or 10 minutes in Dako REAL™ 
Target Retrieval Solution (Dako). After treatment for 30 minutes at room temperature 
(RT) with 0.3% H2O2 in methanol, the sections were incubated for 1 hour at RT in a 
blocking solution containing 1% bovine serum albumin and 0.1% to 0.5% Triton X-100 
in phosphate-buffered saline. 
For immunohistochemical analysis, the following antibodies were used: mouse 
anti-Runx3 (Abnova; 1:2000), rabbit anti-TrkA (RTA; a gift from Dr. L. F. Reichardt, 
University of California, San Francisco, CA; 1:4000), rabbit anti-TrkB (Upstate; 
1:1000), goat anti-TrkC (R&D Systems; 1:1500), rabbit anti-somatostatin (SOM; Protos 
Biotech; 1:2000), rabbit anti-parvalbumin (PV; Swant; 1:2000), mouse anti-NeuN 
(Chemicon; 1:5000), rabbit anti-calretinin (Calr; Swant; 1:2000), rabbit anti-calbindin 
D-28K (CB; Swant; 1:1000), rabbit anti-calcitonin gene-related peptide (CGRP, 
Chemicon; 1:4000), and anti-substance-P (SubP, Protos Biotech; 1:2000) antibodies. 
The sections were incubated for 24 to 48 hours at 4˚C with each of the primary 
antibodies. For single staining, the sections were incubated with a biotinylated 
secondary antibody (Vector Laboratories; 1:500) for 1 hour at RT, followed with the 
peroxidase-conjugated avidin–biotin complex (Vector Laboratories; 1:100) for 30 
minutes at RT. For double or triple staining, cryostat sections were incubated with 
anti-Runx3 antibody, followed by incubation with biotinylated horse anti-mouse IgG 
antibody (Vector Laboratories; 1:500) and Pacific Blue-conjugated streptavidin 
(Invitrogen; 1:500). The sections were then incubated with antibody against TrkA, TrkB, 
TrkC, SOM, or PV, followed by Alexa Fluor 488-labeled donkey anti-rabbit or 
anti-goat IgG antibody or Alexa Fluor 594-labeled donkey anti-rabbit or anti-goat IgG 
antibody (Invitrogen; 1:1000). Images of immunostained samples were collected on a 
LSM510META confocal laser microscope (Carl Zeiss). Samples from Runx3–/– and 
Runx3+/+ littermates and Runx3–/–/Bax–/– and Runx3+/+/Bax–/– littermates were processed 
simultaneously for immunohistochemistry, respectively. 
 
Cell counting and statistical analysis 
For cell counts, large images of TG sections were captured with a CCD camera on an 
A600 microscope with a MosaiX tiling image module (Carl Zeiss) or an 
LSM510META confocal laser microscope (Carl Zeiss) using a 20x objective. To 
estimate the number of immunoreactive (IR) neurons per TG, the number of IR neurons 
was counted in all sections of a 1 in 10 series for newborn mice, or of a 1 in 5 series for 
E10.5 to E13.5 mice, multiplying the average number of IR neurons per section by the 
number of total sections. As described previously (Nakamura et al., 2008), neurons 
were counted if they contained a nucleus and had a signal intensity in the cytoplasm or 
nucleus that was more than 2.5-fold above the noise level for that tissue section. The 
total number of IR neurons was counted from the TGs from each genotype (3-6 TGs 
from three animals at each stage were examined). Quantitative analyses were performed 
on three pairs of embryos or newborns from three independent pregnant mice. Statistical 
analyses were performed using the F test, followed by the Student's t test. Differences 
were considered significant if the probability of error was less than 5%. All results are 
expressed as the mean±SEM. 
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Figures 
 
Figure legends 
 
Figure 1 Changes in the number of TG neuron subtypes in Runx3−/− mice at P0. 
(A’-F’,A’’-F’’) Immunoreactivity of NeuN as a pan-neuronal marker (A’,A’’), TrkA 
(B’,B’’), TrkB (C’,C’’), TrkC (D’,D’’), parvalbumin (PV; E’,E’’), and somatostatin 
(SOM; F’,F’’) in the horizontal sections of TG of Runx3+/+ (A’-F’) and Runx3−/− 
(A’’-F’’) mice at P0. The direction of the sections are shown in F’’. C: caudal, M: 
medical. Boxed areas of immunoreactive neurons are shown at higher magnification in 
the insets at the right bottom of each panel (A’’’-F’’’) Quantification of the total 
number of TG neurons (A’’’) and TG neuron subtypes (B’’’-F’’’) in Runx3+/+ (white 
bars) and Runx3−/− (black bars) mice. Data are shown as mean±SEM; *P<0.0001. Scale 
bar: 200 µm in A. 
 
Figure 2 Co-expression of Runx3 and TG neuron subtype markers at P0. (A’-F’) 
Triple staining of TrkB (green), TrkC (red), and Runx3 (blue) (A’,B’); somatostatin 
(SOM; green), TrkC (red), and Runx3 (blue) (C’,D’); and parvalbumin (PV; green), 
TrkC (red), and Runx3 (blue) (E’,F’) in the sagittal sections of Runx3+/+ TG (A’,C’,E’) 
and Runx3−/− TG (B’,D’,F’). The direction of the sections are shown in B’. C: caudal, 
D: dorsal. Boxed areas of immunoreactive neurons are shown at higher magnification in 
the insets at the top right of each panel. (A’’-F’’) The Venn diagrams show the 
interrelationship of the expression of Runx3, TrkC, and TG neuron subtype markers. 
The area of each circle corresponds to the number of immunoreactive neurons. (G-I) 
Quantification of the number of TrkB−/TrkC+, TrkB+/TrkC−, TrkB+/TrkC+ (G), 
SOM−/TrkC+, SOM+/TrkC−, SOM+/TrkC+ (H), and PV−/TrkC+, PV+/TrkC−, PV+/TrkC+ 
(I) TG neurons in Runx3+/+ (+/+) and Runx3−/− (−/−) mice. The colors used in the Venn 
diagrams and the bar graphs are the same as those indicating the triple staining. Data are 
shown as mean±SEM; *P<0.05, ***P<0.001. Scale bar: 200 µm in A’, scale circle: 
300 neurons in F’’.  
 
Figure 3 Changes in the number of TrkB+ and TrkC+ TG neurons in Runx3−/− 
mice during early development. (A-D) Immunoreactivity of TrkB (A,B) and TrkC 
(C,D) in the sagittal sections of TG of Runx3+/+ (A,C) and Runx3−/− (B,D) mice at 
E10.5 (A’-D’), E11.5 (A’’-D’’), E12.5 (A’’’-D’’’), and E13.5 (A’’’’-D’’’’). The 
direction of the sections are shown in A’’’’. D: dorsal, R: rostral. Boxed areas of 
immunoreactive neurons are shown at higher magnification in the insets at the bottom 
left of each panel. (E,F) Quantifications of the number of TrkB+ (E) and TrkC+ (F) TG 
neurons in Runx3+/+ (white boxes) and Runx3−/− (black boxes) mice from E10.5 to 
E13.5. Data are shown as mean±SEM; *P<0.05, **P<0.01, ***P<0.001. Scale bars: 
150 µm in D’-D’’’’.  
 
Figure 4 Co-expressions of TrkB and TrkC in Runx3−/− TG at E10.5 and E13.5. 
(A’-D’) Triple staining of TrkB (green), TrkC (red), and Runx3 (blue) in the sagittal 
sections of Runx3+/+ (A’,B’) and Runx3−/− (C’,D’) TG at E10.5 (A’,C’) and E13.5 
(B’,D’). The direction of the sections are shown in A’. C: caudal, D: dorsal. Boxed 
areas of immunoreactive neurons are shown at higher magnification in the insets at the 
right bottom of each panel. (A’’-D’’) The Venn diagrams show the interrelationship of 
the expression of TrkB, TrkC, and Runx3 at E10.5 (A’’,C’’) and E13.5 (B’’,D’’). The 
area of each circle corresponds to the number of immunoreactive neurons. (E,F) 
Quantifications of the number of TrkB−/TrkC+, TrkB+/TrkC−, and TrkB+/TrkC+ TG 
neurons in Runx3+/+ (+/+) and Runx3−/− (−/−) mice at E10.5 (E) and E13.5 (F). The 
colors used in the Venn diagrams and the bar graphs are the same as those indicating the 
triple staining. Data are shown as mean±SEM; ***P<0.0001. Scale bars: 250 µm in 
C’,D’; scale circle: 300 neurons in D’’. 
 
Figure 5 TG axon projections to the peripheral targets in Runx3+/+ and Runx3−/− 
mice at E13.5. (A-F) Double staining of TrkC (A,B, red in E,F) and TrkB (C,D, green 
in E,F) in the maxillary region of the coronal sections of Runx3+/+ (A,C,E) and Runx3−/− 
(B,D,F) mice from the same litters. The direction of the sections are shown in E’. D: 
dorsal, M: medial. Boxed areas of immunoreactive axons in A’-F’ are shown at higher 
magnification in each of the right two panels, respectively (A’’-F’’,A’’’-F’’’). TrkC+ 
afferents project to the large whisker vibrissae (L in A’’) and small whisker vibrissae (S 
in A’’’) in Runx3+/+ (A), but not in Runx3−/− (L in B’’, S in B’’’) mice, while TrkB+ 
afferents project to the large whisker vibrissae (L in C’’,D’’) and small whisker 
vibrissae (S in C’’’,D’’’) in both Runx3+/+ (C) and Runx3−/− (D) mice. L: large whisker 
vibrissa, S: small whisker vibrissae. Scale bar: 250 µm in F’. 
 
Figure 6 TG axon projections to the central targets in Runx3+/+ and Runx3−/− mice, 
and Runx3+/+/Bax−/−and Runx3−/−/Bax−/− mice at E13.5. (A-D) Double staining of 
TrkB (A’’’-D’’’, green in A’-D’,A’’’’-D’’’’) and TrkC (A’’-D’’, red in 
A’-D’,A’’’’-D’’’’) in the coronal sections of metencephalon (Met; A,C) and 
myelencephalon (Myel; B,D) of Runx3+/+ (A,B) and Runx3−/− (C,D) mice from the 
same litters. The direction of the sections are shown in A’. D: dorsal, L: lateral. Boxed 
areas of immunoreactive axons in A’-D’ are shown at higher magnification in the each 
right three panels, respectively (A’’-D’’,A’’’-D’’’,A’’’’-D’’’’). TrkC+ axon projections 
were observed in the spinal trigeminal tract (Sp5t), the lateral portion of metencephalon 
and myelencephalon, of Runx3+/+ mice (A’’,B’’, red in A’,B’,A’’’’,B’’’’,), but not in 
Runx3−/− mice (C’,C’’,C’’’’,D’,D’’,D’’’’). Arrows indicate aberrant TrkB+ axon 
projections in the lateral portion of Sp5t of Runx3−/− mice (D’’’, green in D’’’’). 
Arrowheads indicate TrkC+ vestibulocochlear nerve in the myelencephalon of Runx3+/+ 
(B’’,B’’’’) and Runx3−/− (D’’,D’’’’) mice. (E-J) Immunoreactivity of TrkC in TG (E,H), 
metencephalon (F,I) and myelencephalon (G,J) of Runx3+/+/Bax−/− (E-G) and 
Runx3−/−/Bax−/− (H-J) mice at E13.5 from the same litters. Boxed areas of 
immunoreactive TG neurons in E and H are shown at higher magnification in the insets 
at the right bottom of each panel. Boxed areas of immunoreactive axons in F’, G’, I’, J’ 
are shown at higher magnification in each of the right panels (F’’,G’’,I’’,J’’). TrkC+ 
axon projections were observed in Sp5t of Runx3+/+/Bax−/− mice (F,G), but not in 
Runx3−/−/Bax−/− mice (I,J). Arrowheads indicate TrkC+ vestibulocochlear nerve in the 
myelencephalon of Runx3+/+/Bax−/− (G’’) and Runx3−/−/Bax−/− (J’’) mice. Scale bars: 
250 µm in D’,J’; 100 µm in H. 
 
Figure 7 TG axon projections to the Merkel cells in the ORS of large and small 
vibrissae in Runx3+/+ and Runx3−/− mice at P0. (A-F) Double staining of TrkC (A’-F’, 
red in A’’’-F’’’) and TrkB (A’’-F’’, green in A’’’-F’’’) in the large whisker vibrissae of 
Runx3+/+ (A-C) and Runx3−/− (D-F) mice from the same litters. Boxed areas of 
immunoreactive axons B, C in A’’’ and E, F in D’’’ are shown at higher magnification 
in the right three panels, respectively (B,C,E,F). TrkC+ afferents project to the Merkel 
cells in the ORS of large vibrissae in Runx3+/+ (A’,A’’’, arrows in B’,B’’’), but not in 
Runx3−/− (D’,D’’’,E’,E’’’) mice, whereas very few TrkB+ afferents project to the 
Merkel cells in the ORS of large vibrissae in both Runx3+/+ and Runx3−/− mice. TrkB+ 
and TrkC+ afferents projecting to the reticular ending were observed in both Runx3+/+ 
(C) and Runx3−/− (F) mice. (G,H) Double staining of TrkC (G’,H’, red in G’’’,H’’’) and 
TrkA (G’’,H’’, green in G’’’,H’’’) in the small whisker vibrissae and the skin of 
Runx3+/+ (G) and Runx3−/− (H) mice from the same litters. TrkC+ afferents project to 
the Merkel cells in the ORS of small vibrissae in Runx3+/+ (arrows in G’,G’’’), but not 
in Runx3−/− (H’,H’’’) mice, while TrkA+ afferents project to the Merkel cells in ORS of 
small vibrissae in both Runx3+/+ and Runx3−/− mice (G’’,H’’, green in G’’’,H’’’). 
TrkC+/TrkA+ afferents project to the facial skin in both Runx3+/+ and Runx3−/− mice 
(arrowheads in G,H). Scale bars: 100 µm in A’’’’, H’’’; 50 µm in C’’’. 
 
Figure 8 TG axon projections to the brainstem in Runx3+/+ and Runx3−/− mice at 
P0. (A,B) Double staining of TrkC (A’’,B’’, red in A’,B’,A’’’’,B’’’’) and TrkB 
(A’’’,B’’’, green in A’,B’,A’’’’,B’’’’) in the coronal sections of brainstem (BS) of 
Runx3+/+ (A) and Runx3−/− (B) mice from the same litters at P0. The direction of the 
sections are shown in B’. D: dorsal, M: medial.  Boxed areas of immunoreactive axons 
in A’, B’ are shown at higher magnification in each of the right three panels, 
respectively (A’’-A’’’’,B’’-B’’’’). The white dotted line outlines the spinal trigeminal 
nucleus pars interpolaris (Sp5I; upper dotted lines) and caudalis (Sp5C; lower dotted 
lines), based on an atlas of the developing mouse brain at P0 (Paxinos et al., 2007). 
TrkC+ axons project to Sp5I and Sp5C in Runx3+/+ mice (A’’, red in A’,A’’’’), but not 
to Sp5I in Runx3−/− mice (B’’, red in B’,B’’’’), while TrkB+ axons project to Sp5C and 
SP5I in both Runx3+/+ and Runx3−/− mice (A’’’,B’’’, green in A’,B’,A’’’’,B’’’’). Scale 
bars: 500 µm in A’, 250 µm in A’’’’.  







 
 
Supplemental materials 
 
Supplemental figure legends 
 
Figure S1 Number of TG neuron subtypes in Runx3−/− mice at P0. (A’-D’,A’’-D’’) 
Immunoreactivity of calretinin (Calr; A’,A’’), calbindin-D28K (CB; B’,B’’), calcitonin 
gene-related peptide (CGRP; C’,C’’), and substance-P (SubP; D’,D’’) in the horizontal 
sections of Runx3+/+ (A’-D’) and Runx3−/− (A’’-D’’) TG at P0. The direction of the 
sections are shown in A’. C: caudal, L: lateral. Boxed areas of immunoreactive (IR) 
neurons are shown at higher magnification in the insets at the bottom right of each panel. 
(A’’’-D’’’) Quantification of the number of TG neuron subtypes in Runx3+/+ (white 
bars) and Runx3−/− (black bars) mice. Data are shown as mean±SEM. Scale bar: 200 µm 
in D’. 
  
Figure S2 Number of TrkA+ and NeuN+ TG neurons in Runx3−/− mice at E11.5 and 
E13.5. (A-D) Immunoreactivity of TrkA (A,B) and NeuN (C,D) in the sagittal sections 
of TG of Runx3+/+ (A,C) and Runx3−/− (B,D) mice at E11.5 (A’-D’) and E13.5 
(A’’-D’’). The direction of the sections are shown in A’. D: dorsal, R: rostral. Boxed 
areas of immunoreactive (IR) neurons are shown at higher magnification in the insets at 
the bottom left of each panel. (E,F) Quantification of the number of TrkA+ and NeuN+ 
TG neurons in Runx3+/+ (white bars) and Runx3−/− (black bars) mice. Data are shown as 
mean±SEM; *P<0.05. Scale bars: 200 µm in D’, 150 µm in D’’. 
 
Figure S3 No difference in the number of caspase3+ TG cells between Runx3+/+ and 
Runx3−/− mice from E11.5 to P0. (A-D) Immunoreactivity of caspase3 in the sagittal 
sections of TG of Runx3+/+ (A’-D’) and Runx3−/− (A’’-D’’) mice at E11.5 (A’,A’’), 
E13.5 (B’,B’’), E15.5 (C’,C’’), and P0 (D’,D’’). The direction of the sections are shown 
in C’. D: dorsal, R: rostral. Boxed areas of immunoreactive cells are shown at higher 
magnification in the insets at the bottom left of each panel. (E) Quantitative analysis of 
the number of caspase3+ TG cells in Runx3+/+ (white boxes) and Runx3−/− (black boxes) 
mice. Data are shown as mean ±SEM.  Scale bar: 150 µm in A’. 
 
Figure S4 DiI-labeled TG axons in the brainstem of Runx3–/– mice. (A-L) 
Photomicrographs showing DiI-labeled TG axons in the coronal sections of brain stem 
of Runx3+/+ (A,B,E,F,D,J) and Runx3–/– mice (C,D,G,H,K,L) at E13.5 (A-D), E16.5 
(E-H), and P0 (I-L). The direction of the sections are shown in I. D: dorsal, L: lateral. 
Boxed areas of DiI-labeled axons in E,G,I,K are shown at higher magnification to the 
right of each panel, respectively (F,H,J,L). DiI-labeling of axons of Runx3−/− mice 
seemed to be less intense than that of Runx3+/+ at each embryonic stage. Met: 
metencephalon, Myel: myelencephalon, Sp5t: spinal trigeminal tract, Sp5I: the spinal 
trigeminal nucleus pars interpolaris. Scale bar: 150 µm in D.  
 
Figure S5 Runx3 expression in the TG at E13.5. (A) Lateral view of whole-mount 
lacZ staining of Runx3+/− mouse. (B) LacZ stained TG in A is shown at higher 
magnification. Runx3 was expressed strongly in the maxillary lobe and much more 
weakly in the ophthalmic and mandibular lobes. TG: trigeminal ganglion, op: 
ophthalmic lobe, mx: maxillary lobe, md: mandibular lobe. Scale bars: 1 mm in A, 500 
µm in B. 
 



 
